Robert J Davies

This inventor holds 48 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Vertex Pharmaceuticals, Inc., Other. Active years: 2001-2020.

USPTO Granted Patents = 48 (Patent Applications = 4)

% Patents Active = 29.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 17)

Average Co-Inventor Count = 3.7

ph-index = 22

Forward Citations = 1,593(Granted Patents)

Location History:

Wamego, KS (US) (2001 - 2003)
Somerville, MA (US) (2007 - 2011)
Cambridge, MA (US) (2003 - 2014)
Watertown, MA (US) (2011 - 2019)
Arlington, MA (US) (2003 - 2020)

Company Filing History:

44 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2020

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

Isoindolinone

Triazoles

Demyelinating Diseases

Phosphatidylinositol

Caspases

Muscarinic Receptors

c-MET

Prodrugs

Aminotriazoles

Pyrazole Compounds

Diaminotriazoles

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10766869 - Triazoles for the treatment of demyelinating dieases (2020-09-08),

2. 10183933 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2019-01-22),

3. 10118904 - Triazoles for the treatment of Demyelinating Diseases (2018-11-06),

4. 9994613 - Prodrug of an ICE inhibitor (2018-06-12),

5. 9676759 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2017-06-13),

6. 9487555 - Prodrug of an ice inhibitor (2016-11-08),

7. 9156880 - Prodrug of an ice inhibitor (2015-10-13),

8. 8691848 - Inhibitors of caspases (2014-04-08),

9. 8524906 - Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase (2013-09-03),

10. 8524720 - Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors (2013-09-03),

11. 8466288 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2013-06-18),

12. 8344153 - Inhibitors of phosphatidylinositol 3-kinase (2013-01-01),

13. 8329662 - Prodrug of an ICE inhibitor (2012-12-11),

14. 8304423 - Modulators of muscarinic receptors (2012-11-06),

15. 8232406 - c-MET protein kinase inhibitors (2012-07-31),

Title: The Innovative Journey of Robert J Davies

Introduction: Robert J Davies, a visionary inventor based in Arlington, MA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Robert J Davies holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Robert J Davies has established himself as a leading figure in the tech industry. He has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous research projects and product developments.

Collaborations: Throughout his career, Robert J Davies has collaborated with top engineers, scientists, and researchers from around the world. His collaborative efforts have resulted in the successful development and commercialization of cutting-edge technologies that have transformed industries.

Conclusion: Robert J Davies' relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of inventors and shape the future of technology.